Database for multicountry clinical research funding opportunities in Europe

The ERA4Health inventory of funding resources for multicountry clinical research provides a structured overview of European, national and transnational programmes that can finance non‑commercial, investigator‑initiated clinical studies in Europe. It first explains why multinational clinical research is important for addressing unmet health needs and generating practice‑changing evidence, then summarises common funding and operational barriers that currently limit such studies, especially for academic sponsors and smaller countries.

In the main body, the inventory lists concrete funding schemes grouped by funder and mechanism, including EU‑level partnerships and joint transnational calls, national and regional agencies that support pragmatic, comparative‑effectiveness or drug‑repurposing trials, disease‑specific foundations and networks, and infrastructures or initiatives that provide complementary support for coordination and trial management. A dedicated glossary further explains the different clinical trial designs and related terminology so that readers can interpret eligibility criteria and study types consistently.

As a practical tool for investigators, research support offices and clinical trial units, the inventory can be used to screen for funding opportunities suited to non‑commercial multicountry clinical trials and feasibility studies, compare typical eligibility and design requirements across schemes, and plan coordinated applications that align multicentre trial proposals with the objectives of the ERA4Health Partnership and related European and national programmes.